Source: Advanced Cell Technology, Inc.
Date: May 7, 2007
Summary:
Advanced Cell Technology, Inc. reported for the first time that hemangioblast (blood) precursor cells derived from human embryonic stem (hES) cells can be used to achieve vascular repair. The research, which appears today online (ahead of print) in the journal Nature Methods, by Advanced Cell Technology (ACT) and its collaborators, describes an efficient method for generating large numbers of bipotential progenitors—known as hemangioblasts—from hES cells that are capable of differentiating into blood vessels, as well as into all blood and immune cell lineages.
